Factors associated with fear of lymphedema after treatment for breast cancer

Oncology Nursing Forum

Volumn 41, Issue 5, 2014, Pages 473-483

  Jammallo, Lauren S ^a   Miller, Cynthia L ^a   Horick, Nora K ^a   Skolny, Melissa N ^a   O'Toole, Jean ^a   Specht, Michelle C ^a   Taghian, Alphonse G ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; Fear; Lymphedema; Perometer; Quality of life

Indexed keywords

ADULT; ADVERSE EFFECTS; AGE; AGED; ATTITUDE TO HEALTH; BREAST NEOPLASMS; COMPLICATION; FEAR; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPHEDEMA; MASTECTOMY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATIENT EDUCATION; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDY; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE;

ADULT; AGE FACTORS; AGED; ATTITUDE TO HEALTH; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEAR; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHEDEMA; MASTECTOMY; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84908470076     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/14.ONF.473-483     Document Type: Article

References (55)

1. Ahmed, R.L., Prizment, A., Lazovich, D., Schmitz, K.H., & Folsom, A.R. (2008). Lymphedema and quality of life in breast cancer survivors: The Iowa Women's Health Study. Journal of Clinical Oncology, 26, 5689-5696. doi:10.1200/JCO.2008.16.4731
2. Ahmed, R.L., Thomas, W., Yee, D., & Schmitz, K.H. (2006). Ran domized controlled trial of weight training and lymphedema in breast cancer survivors. Journal of Clinical Oncology, 24, 2765-2772. doi:10.1200/JCO.2005.03.6749
3. Ancukiewicz, M., Russell, T.A., Otoole, J., Specht, M., Singer, M., Kelada, A., . . . Taghian, A.G. (2011). Standardized method for quantification of developing lymphedema in patients treated for breast cancer. International Journal of Radiation Oncology, Biology, Physics, 79, 1436-1443. doi:10.1016/j.ijrobp.2010.01.001
4. Armer, J.M., Radina, M.E., Porock, D., & Culbertson, S.D. (2003). Predicting breast cancer-related lymphedema using self-reported symptoms. Nursing Research, 52, 370-379.
5. Armer, J.M., & Stewart, B.R. (2010). Post-breast cancer lymphedema: Incidence increases from 12 to 30 to 60 months. Lymphology, 43, 118-127.
6. Ashikaga, T., Krag, D.N., Land, S.R., Julian, T.B., Anderson, S.J., Brown, A.M., . . . Wolmark, N. (2010). Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. Journal of Surgical Oncology, 102, 111-118. doi:10.1002/jso.21535
7. Beaton, D.E., Katz, J.N., Fossel, A.H., Wright, J.G., Tarasuk, V., & Bombardier, C. (2001). Measuring the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. Journal of Hand Therapy, 14, 128-146.
8. Bevilacqua, J.L., Kattan, M.W., Changhong, Y., Koifman, S., Mattos, I.E., Koifman, R.J., & Bergmann, A. (2012). Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer. Annals of Surgical Oncology, 19, 2580-2589. doi:10.1245/s10434-012-2290-x
9. Bicego, D., Brown, K., Ruddick, M., Storey, D., Wong, C., & Harris, S.R. (2009). Effects of exercise on quality of life in women living with breast cancer: A systematic review. Breast Journal, 15, 45-51.
10. Bosompra, K., Ashikaga, T., O'Brien, P.J., Nelson, L., Skelly, J., & Beatty, D.J. (2002). Knowledge about preventing and managing lymphedema: A survey of recently diagnosed and treated breast cancer patients. Patient Education and Counseling, 47, 155-163.
11. Cemal, Y., Pusic, A., & Mehrara, B.J. (2011). Preventative measures for lymphedema: Separating fact from fiction. Journal of the American College of Surgeons, 213, 543-551. doi:10.1016/j.jamcollsurg.2011.07.001
12. Chachaj, A., Malyszczak, K., Pyszel, K., Lukas, J., Tarkowski, R., Pudelko, M., . . . Szuba, A. (2010). Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psycho-Oncology, 19, 299-305. doi:10.1002/pon.1573
13. Cheema, B., Gaul, C.A., Lane, K., & Fiatarone Singh, M.A. (2008). Progressive resistance training in breast cancer: A systematic review of clinical trials. Breast Cancer Research and Treatment, 109, 9-26. doi:10.1007/s10549-007-9638-0
14. Collins, L.G., Nash, R., Round, T., & Newman, B. (2004). Perceptions of upper-body problems during recovery from breast cancer treatment. Supportive Care in Cancer, 12, 106-113. doi:10.1007/s00520-003-0554-5
15. Cormier, J.N., Xing, Y., Zaniletti, I., Askew, R.L., Stewart, B.R., & Armer, J.M. (2009). Minimal limb volume change has a significant impact on breast cancer survivors. Lymphology, 42, 161-175.
16. Costanzo, E.S., Lutgendorf, S.K., Mattes, M.L., Trehan, S., Robinson, C.B., Tewfik, F., & Roman, S.L. (2007). Adjusting to life after treatment: Distress and quality of life following treatment for breast cancer. British Journal of Cancer, 97, 1625-1631. doi:10.1038/sj.bjc.6604091
17. Coster, S., Poole, K., & Fallowfield, L.J. (2001). The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively. Breast Cancer Research and Treatment, 68, 273-282.
18. Deltombe, T., Jamart, J., Recloux, S., Legrand, C., Vandenbroeck, N., Theys, S., & Hanson, P. (2007). Reliability and limits of agreement of circumferential, water displacement, and optoelectronic volumetry in the measurement of upper limb lymphedema. Lymphology, 40, 26-34.
19. DiSipio, T., Rye, S., Newman, B., & Hayes, S. (2013). Incidence of unilateral arm lymphoedema after breast cancer: A systematic review and meta-analysis. Lancet Onocology, 14, 500-515.
20. Erickson, V.S., Pearson, M.L., Ganz, P.A., Adams, J., & Kahn, K.L. (2001). Arm edema in breast cancer patients. Journal of the National Cancer Institute, 93, 96-111. doi:10.1093/jnci/93.2.96
21. Fu, M.R., Ridner, S.H., & Armer, J. (2009). Post-breast cancer. Lymphedema: Part 1. American Journal of Nursing, 109, 48-54. doi:10.1097/01.NAJ.0000357172.94131.58
22. Greenslade, M.V., & House, C.J. (2006). Living with lymphedema: A qualitative study of women's perspectives on prevention and management following breast cancer-related treatment. Canadian Oncology Nursing Journal, 16, 165-179.
23. Jain, M.S., Danoff, J.V., & Paul, S.M. (2010). Correlation between bioelectrical spectroscopy and perometry in assessment of upper extremity swelling. Lymphology, 43, 85-94.
24. Kwan, M.L., Darbinian, J., Schmitz, K.H., Citron, R., Partee, P., Kutner, S.E., & Kushi, L.H. (2010). Risk factors for lymphedema in a prospective breast cancer survivorship study: The Pathways Study. Archives of Surgery, 145, 1055-1063. doi:10.1001/archsurg.2010.231
25. Kwan, M.L., Shen, L., Munneke, J.R., Tam, E.K., Partee, P.N., André, M., . . . Thiadens, S.R. (2012). Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system. Breast Cancer Research and Treatment, 135, 591-602. doi:10.1007/s10549-012-2199-x
26. Lee, T.S., Kilbreath, S.L., Sullivan, G., Refshauge, K.M., & Beith, J.M. (2007). The development of an arm activity survey for breast cancer survivors using the Protection Motivation Theory. BMC Cancer, 7, 75. doi:10.1186/1471-2407-7-75
27. Lee, T.S., Kilbreath, S.L., Sullivan, G., Refshauge, K.M., Beith, J.M., & Harris, L.M. (2009). Factors that affect intention to avoid strenuous arm activity after breast cancer surgery. Oncology Nursing Forum, 36, 454-462. doi:10.1188/09.ONF.454-462
28. Lee, Y.M., Mak, S.S., Tse, S.M., & Chan, S.J. (2001). Lymphoedema care of breast cancer patients in a breast care clinic: A survey of knowledge and health practice. Supportive Care in Cancer, 9, 634-641.
29. McLaughlin, S.A. (2012). Lymphedema: Separating fact from fiction. Oncology, 26, 242-249.
30. McLaughlin, S.A., Bagaria, S., Gibson, T., Arnold, M., Diehl, N., Crook, J., . . . Nguyen, J. (2013). Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery. Journal of the American College of Surgeons, 216, 380-389. doi:10.1016/j.jamcollsurg.2012.11.004
31. Mertz, B.G., Bistrup, P.E., Johansen, C., Dalton, S.O., Deltour, I., Kehlet, H., & Kroman, N. (2012). Psychological distress among women with newly diagnosed breast cancer. European Journal of Oncology Nursing, 16, 439-443. doi:10.1016/j.ejon.2011.10.001
32. National Lymphedema Network. (2012). Position statement of the National Lymphedema Network: Summary of lymphedema risk reduction practices. Retrieved from http://www.lymphnet.org/pdfDocs/nlnriskreduction-summary.pdf
33. National Lymphedema Network. (2013). Position statement of the National Lymphedema Network: Exercise. Retrieved from http://www.lymphnet.org/pdfDocs/nlnexercise.pdf
34. Norman, S.A., Localio, A.R., Kallan, M.J., Weber, A.L., Torpey, H.A., Potashnik, S.L., . . . Solin, L.J. (2010). Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiology, Biomarkers and Prevention, 19, 2734-2746. doi:10.1158/1055-9965.EPI-09-1245
35. Paskett, E.D., Naughton, M.J., McCoy, T.P., Case, L.D., & Abbott, J.M. (2007). The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiology, Biomarkers and Prevention, 16, 775-782. doi:10.1158/1055-9965.EPI-06-0168
36. Paskett, E.D., & Stark, N. (2000). Lymphedema: Knowledge, treatment, and impact among breast cancer survivors. Breast Journal, 6, 373-378. doi:10.1046/j.1524-4741.2000.99072.x
37. Radina, M.E., Armer, J.M., Culbertson, S.D., & Dusold, J.M. (2004). Post-breast cancer lymphedema: Understanding women's knowledge of their condition. Oncology Nursing Forum, 31, 97-104.
38. Ridner, S.H. (2005). Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema. Supportive Care in Cancer, 13, 904-911. doi:10.1007/s00520-005-0810-y
39. Ridner, S.H., Dietrich, M.S., Deng, J., Bonner, C.M., & Kidd, N. (2009). Bioelectrical impedance for detecting upper limb lymphedema in nonlaboratory settings. Lymphatic Research and Biology, 7, 11-15. doi:10.1089/lrb.2008.1003
40. Ridner, S.H., Montgomery, L.D., Hepworth, J.T., Stewart, B.R., & Armer, J.M. (2007). Comparison of upper limb volume measurement techniques and arm symptoms between healthy volunteer and individuals with known lymphedema. Lymphology, 40, 35-46.
41. Sagen, A., Karesen, R., & Risberg, M.A. (2009). Physical activity for the affected limb and arm lymphedema after breast cancer surgery. A prospective, randomized controlled trial with two years follow-up. Acta Oncologica, 48, 1102-1110. doi:10.3109/02841860903061683
42. Sander, A.P., Wilson, J., Izzo, N., Mountford, S.A., & Hayes, K.W. (2012). Factors that affect decisions about physical activity and exercise in survivors of breast cancer: A qualitative study. Physical Therapy, 92, 525-536. doi:10.2522/ptj.20110115
43. Schmitz, K.H., Ahmed, R.L., Troxel, A., Cheville, A., Smith, R., Lewis-Grant, L., . . . Greene, Q.P. (2009). Weight lifting in women with breast-cancer-related lymphedema. New England Journal of Medicine, 361, 664-673. doi:10.1056/NEJMoa0810118
44. Shih, Y.C., Xu, Y., Cormier, J.N., Giordano, S., Ridner, S.H., Buchholz, T.A., . . . Elting, L.S. (2009). Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: A 2-year follow-up study. Journal of Clinical Oncology, 27, 2007-2014. doi:10.1200/JCO.2008.18.3517
45. Smoot, B.J., Wong, J.F., & Dodd, M.J. (2011). Comparison of diagnostic accuracy of clinical measures of breast cancer-related lymphedema: Area under the curve. Archives of Physical Medicine and Rehabilitation, 92, 603-610. doi:10.1016/j.apmr.2010.11.017
46. Soran, A., Wu, W.C., Dirican, A., Johnson, R., Andacoglu, O., & Wilson, J. (2011). Estimating the probability of lymphedema after breast cancer surgery. American Journal of Clinical Oncology, 34, 506-510.
47. Specht, M.C., Miller, C.L., Russell, T.A., Horick, N., Skolny, M.N., O'Toole, J.A., . . . Taghian, A.G. (2013). Defining a threshold for intervention in breast cancer-related lymphedema: What level of arm volume increase predicts progression? Breast Cancer Research and Treatment, 140, 485-494. doi:10.1007/s10549-013-2655-2
48. Stanton, A.W., Northfield, J.W., Holroyd, B., Mortimer, P.S., & Levick, J.R. (1997). Validation of an optoelectronic limb volumeter (Perometer). Lymphology, 30, 77-97.
49. Stout Gergich, N.L., Pfalzer, L.A., McGarvey, C., Springer, B., Gerber, L.H., & Soballe, P. (2008). Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer, 112, 2809-2819. doi:10.1002/cncr.23494
50. Tam, E.K., Shen, L., Munneke, J.R., Ackerson, L.M., Partee, P.N., Somkin, C.P., . . . Kwan, M.L. (2012). Clinician awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery setting. Breast Cancer Research and Treatment, 131, 1029-1038. doi:10.1007/s10549-011-1829-z
51. Tewari, N., Gill, P.G., Bochner, M.A., & Kollias, J. (2008). Comparison of volume displacement versus circumferential arm measurements for lymphoedema: Implications for the SNAC trial. ANZ Journal of Surgery, 78, 889-893. doi:10.1111/j.1445-2197.2008.04686.x
52. Thomas-MacLean, R., Miedema, B., & Tatemichi, S.R. (2005). Breast cancer-related lymphedema: Women's experiences with an underestimated condition. Canadian Family Physician, 51, 246-247.
53. Tsai, R.J., Dennis, L.K., Lynch, C.F., Snetselaar, L.G., Zamba, G.K., & Scott-Conner, C. (2009). The risk of developing arm lymphedema among breast cancer survivors: A meta-analysis of treatment factors. Annals of Surgical Oncology, 16, 1959-1972.
54. Tudor-Locke, C., Ainsworth, B.E., Washington, T.L., & Troiano, R. (2011). Assigning metabolic equivalent values to the 2002 census occupational classification system. Journal of Physical Activity and Health, 8, 581-586.
55. Ward, L., Winall, A., Isenring, E., Hills, A., Czerniec, S., Dylke, E., & Kilbreath, S. (2011). Assessment of bilateral limb lymphedema by bioelectrical impedance spectroscopy. International Journal of Gynecological Cancer, 21, 409-418. doi:10.1097/IGC.0b013e31820866e1